[Award Report] FY2022 Takemi Memorial Award for Research in Seizon and Life Sciences (The Takemi Memorial Award for Research in Seizon and Life Sciences, December 2022)
date : 3/3/2023
Tags: Other activities
Health and Global Policy Institute (HGPI) Board Member and CEO Mr. Ryoji Noritake has been awarded the FY2022 Takemi Memorial Award for Research in Seizon and Life Sciences. Mr. Noritake was recognized for his contributions to the development of a mature civil society by creating opportunities for diverse stakeholders in society and the parties most affected in various areas to come together for exchanges of opinion that surpass the positions of individuals. At Mr. Noritake’s request, the monetary prize from the award has been donated to HGPI.

■ Introducing the Takemi Memorial Award for Research in Seizon and Life Sciences
The Takemi Memorial Award for Research in Seizon and Life Sciences recognizes individuals or groups who will serve as future leaders of Japan and have made noteworthy achievements through innovative research and practical activities in basic, clinical, and social medicine in life sciences or related fields. (From the website of the Takemi Memorial Award for Research in Seizon and Life Sciences.)
For further details, please refer to the website of the Takemi Memorial Award for Research in Seizon and Life Sciences.
Top Research & Recommendations Posts
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Announcement] HGPI Endorses the “Belém Health Action Plan” (November 14, 2025)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Policy Recommendations] Recommendations on Strategic Investments in Policies for Brain Health to Revitalize Japan: Hopes for the New Administration (December 1, 2025)
- [Research Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Final Version) (November 14, 2024)
- [Research Report] The Public Opinion Survey on Mental Health (August 12, 2022)
Featured Posts
-
2025-12-09
[Event Report] Special Seminar “Rising to New Challenges in Health Sciences for Future Society: Novel Developments in the Field of Epilepsy in Japan and Globally” Belgium Pavilion Special Seminar, World Expo 2025 Osaka, Kansai (September 18, 2025)
-
2025-12-11
[Event Report] Core Components of Universal Health Coverage (UHC): Achieving “Healthcare Without Financial Hardship” in Asia-Pacific and Japan (December 5, 2025)
-
2025-12-12
[Registration Open] Meaningful Involvement Promotion Project Urgent Symposium “The New Takaichi Administration and Central Social Insurance Medical Council Reform – Ensuring Patients’ Voices are Heard” (January 22, 2026)
-
2025-12-12
[Registration Open] (Webinar) The 140th HGPI Seminar “Early Detection to Reduce COPD Disease Burden: Connecting Clinical Frontiers with Health Policy” (January 27, 2026)



